| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | IQV | Common Stock | Gift | $0 | -24,000 | -63% | $0.000000 | 14,344 | 20 Dec 2021 | By Trust | F1, F2 |
| transaction | IQV | Common Stock | Purchase | $2,729,300 | +10,000 | +70% | $272.93 | 24,344 | 22 Dec 2021 | By Trust | F2, F3 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | IQV | Deferred Shares | Award | $27,389 | +149 | $183.82 | 149 | 09 Feb 2021 | Common Stock | 149 | Direct | F4 | ||
| transaction | IQV | Deferred Shares | Award | $27,623 | +129 | +87% | $214.13 | 278 | 15 Apr 2021 | Common Stock | 129 | Direct | F4 | |
| transaction | IQV | Deferred Shares | Award | $27,306 | +111 | +40% | $246.00 | 389 | 14 Jul 2021 | Common Stock | 111 | Direct | F4 | |
| transaction | IQV | Deferred Shares | Award | $27,658 | +108 | +28% | $256.09 | 497 | 26 Oct 2021 | Common Stock | 108 | Direct | F4 |
| Id | Content |
|---|---|
| F1 | 20,000 shares were donated to the Danhakl Family Foundation for no remuneration. |
| F2 | Shares held in the Danhakl Revocable Family Trust. |
| F3 | The price reported in Column 4 is a weighted average price for shares purchased in multiple transactions. The purchase prices range from $270.67 to $274.52 per share. The reporting person has provided to the issuer, and undertakes to provide to the Commission staff or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F4 | Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. |